Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Biochemical and Biophysical Research Communications|January 11, 2014
PeptiSite: a structural database of peptide binding sites in 4DChayan Acharya, Irina Kufareva, Andrey V Ilatovskiy, et al.
Molecular Pharmaceutics|October 14, 2010
Structural determinants for transport across the intestinal bile acid transporter using C-24 bile acid conjugatesRana Rais, Chayan Acharya, Alexander D Mackerell, et al.
Current Computer-Aided Drug Design|September 3, 2010
Recent advances in ligand-based drug design: relevance and utility of the conformationally sampled pharmacophore approachChayan Acharya, Andrew Coop, James E Polli, et al.
Journal of Clinical Pharmacology|December 1, 2022
Population Pharmacokinetics and Exposure-Response for Dapirolizumab Pegol From a Phase 2b Trial in Patients With Systemic Lupus ErythematosusChayan Acharya, Mats O Magnusson, Pavan Vajjah, et al.
Pharmaceutical Research|April 23, 2009
Inhibition requirements of the human apical sodium-dependent bile acid transporter (hASBT) using aminopiperidine conjugates of glutamyl-bile acidsPablo M González, Chayan Acharya, Alexander D Mackerell, et al.
Molecular Pharmaceutics|August 20, 2008
Computational model for predicting chemical substituent effects on passive drug permeability across parallel artificial membranesChayan Acharya, Paul R Seo, James E Polli, et al.
Bioconjugate Chemistry|October 26, 2010
Structural requirements of the ASBT by 3D-QSAR analysis using aminopyridine conjugates of chenodeoxycholic acidXiaowan Zheng, Yongmei Pan, Chayan Acharya, et al.
Journal of Medicinal Chemistry|May 28, 2010
Molecular switch controlling the binding of anionic bile acid conjugates to human apical sodium-dependent bile acid transporterRana Rais, Chayan Acharya, Gasirat Tririya, et al.
Journal of Pharmaceutical Sciences|November 24, 2011
Identification of novel nonsteroidal compounds as substrates or inhibitors of hASBTVidula Kolhatkar, Lei Diao, Chayan Acharya, et al.
Pageof 2